Al-Dorra Holdings to IPO New Pharmaceutical Subsidiary, Hail First Pharma Inc.
2011年1月21日 - 4:15AM
Marketwired
Al-Dorra Holdings, a privately held Kuwaiti company, announced
today the intent to IPO its newly formed subsidiary Hail First
Pharma Inc. in the first quarter of this year.
According to the company, Hail First Pharma Inc. is the result
of several acquisitions and or joint-ventures with international
pharmaceutical companies including but not limited to Spencer
Pharmaceutical Inc., a public traded company listed on the US OTC
Markets (PINKSHEETS: SPPH). Hail First Pharma is poised to become
the leading pharmaceutical of the Middle East with plans on
developing a state-of-the-art research center in the Prince
Abdulaziz bin Mousaed Economic City in the Northern province of
Hail Saudi Arabia.
"The acquisitions, joint-venture as well as the financial
participation from various regional and international partners will
make this IPO a tremendous success," said Hussain Al-Awaid,
President of Al-Dorra. "The recently announced acquisition of
Spencer Pharmaceutical will provide a platform for development and
enable us to immediate market a diabetic drug to the region
desperately in need," further added Mr. Al-Awaid.
Important Information
About Forward-Looking Statements in this press release may be
"forward-looking statements" within the meaning of the Private
Securities Litigation Reform Act of 1995. Words such as
"anticipate," "believe," "estimate," "expect," "intend" and similar
expressions, as they relate to the company or its management,
identify forward-looking statements. These statements are based on
current expectations, estimates and projections about the company's
business based, in part, on assumptions made by management. These
statements are not guarantees of future performance and involve
risks, uncertainties and assumptions that are difficult to predict.
Therefore, actual outcomes and results may, and probably will,
differ materially from what is expressed or forecasted in such
forward-looking statements due to numerous factors, including those
described above. In addition, such statements could be affected by
risks and uncertainties related to the exploration for and
development of mineralized material, product demand, market and
customer acceptance, competition, pricing and development
difficulties, as well as general industry and market conditions and
growth rates and general economic conditions. Any forward-looking
statements speak only as of the date on which they are made, and
the company does not undertake any obligation to update any
forward-looking statement to reflect events or circumstances after
the date of this release. Information on the Company's website does
not constitute a part of this release.
Contact: Hussain Al-Awaid Tel +971-5061-25585
Spencer Pharmaceutical (CE) (USOTC:SPPH)
過去 株価チャート
から 5 2024 まで 6 2024
Spencer Pharmaceutical (CE) (USOTC:SPPH)
過去 株価チャート
から 6 2023 まで 6 2024
Real-Time news about Spencer Pharmaceutical Inc (CE) (その他OTC): 0 recent articles
その他のHail First Pharma Inc.ニュース記事